Knowing quickly if your treatment is working is fundamental to a successful recovery. A liquid biopsy (ctDNA, cfDNA) test shows us immediately – often within a week – how effective your treatment is.
In addition to identifying any mutations involved in your cancer, this blood test can be used both during your treatment, and after, to monitor whether your cancer is growing or shrinking. Liquid biopsies (ctDNA, cfDNA) show us how well your treatment is working through this process:
Based on the amount of a specific mutation – compared to the non-mutated DNA – found in your blood, we can tell how well your treatment is working. This is because this innovative blood test provides us with instant, real-time information about all the tumours in your body, simultaneously.
Let’s use an example to show why liquid biopsies (ctDNA, cfDNA) are so effective. Say we’re using a drug to target a known mutation that’s been shown to be driving your cancer. For this example, we’ll say it’s an EGFR mutation (a mutation common in non-small cell lung cancer).
This liquid biopsy (ctDNA, cfDNA) test is incredibly accurate:
This blood test is cheaper, simpler, less invasive, and faster than other types of genetic tests (like comprehensive genetic panels) and imaging tools like a PET/CT scan, CT scan, or MRI. This makes it that much easier for you to continue monitoring your body for years after treatment – and ensure that you stay cancer-free.
Please reach out today if you think you might have cancer, or have received a diagnosis of cancer. CTOAM’s precision oncology specialists can help you access the most advanced tests and treatments to ensure you have the optimal treatment outcomes.
Register for a Precision Second Opinion to discover how we can help you to reduce stress and dramatically increase treatment success. Time is of the essence with cancer: the future of your health is worth a phone call.
Get the latest advancements in cancer care delivered straight to your inbox each month!